Shilpa Medicare receives European marketing authorization for Tadalafil Orodispersible Films for erectile dysfunction Ruchika Sharma11 Jan 2025 2:06 PM ISTShilpa Medicare has informed in a BSE filing that the Company has received marketing authorization from Portugal, Europe, for Tadalafil...
Shilpa Medicare receives Eurasia GMP approval for 2 Telangana units Ruchika Sharma28 Dec 2024 11:30 AM ISTKarnataka: In a BSE filing, Shilpa Medicare informed that its Unit IV and Unit VII in Telangana have received Good Manufacturing Practice...
Shilpa Medicare receives Europe GMP Certification for Hyderabad facility Ruchika Sharma22 Dec 2024 3:31 PM ISTKarnataka: Shilpa Medicare has received the Good Manufacturing Practice (GMP) Certification after the successful closure of the EMA,...
Shilpa Medicare-Zydus JV gets USFDA nod for Imkeldi for certain forms of leukemia, other cancers Ruchika Sharma27 Nov 2024 5:26 PM ISTKarnataka: Shilpa Medicare's Joint Venture Oncosol (50:50 JV with Liqmeds Lifecare Limited, a Zydus group company and Koana Healthcare Limited,...
Shilpa Medicare gets CDSCO panel nod to conduct Phase III clinical trials for Recombinant Human Albumin 20% Ruchika Sharma27 Nov 2024 11:30 AM ISTNew Delhi: In relation to the successful completion of Phase I clinical trials, Shilpa Medicare Ltd has announced that the Subject Expert...
Shilpa Pharma Lifesciences gets CEP from EDQM for API, Octreotide Ruchika Sharma19 Nov 2024 11:19 AM ISTKarnataka: Shilpa Medicare has announced that the Company’' 100% subsidiary, Shilpa Pharma Lifesciences Limited has received a certificate of...
Shilpa Medicare gets four USFDA observations for Bengaluru facility Ruchika Sharma4 Nov 2024 3:58 PM ISTRaichur: Shilpa Medicare has announced that the US Food and Drug Administration (USFDA) has issued Form 483 with four observations at the...
Shilpa Pharma Lifesciences receives CEP from EDQM for API, Desmopressin Ruchika Sharma6 Oct 2024 10:00 AM ISTKarnataka: Shilpa Medicare Limited's 100% subsidiary, Shilpa Pharma Lifesciences Limited has received certificate of suitability (CEP) from EDQM...
Dr Sridevi Khambhampaty appointed as CEO of Shilpa Biologicals Ruchika Sharma20 Sept 2024 11:30 AM ISTKarnataka: Shilpa Medicare has announced the appointment of Dr Sridevi Khambhampaty, as Chief Executive Officer (CEO) of Shilpa Biologicals...
Shilpa Medicare gets USFDA nod for Bortezomib Injection for multiple myeloma Ruchika Sharma28 Aug 2024 11:57 AM ISTKarnataka: Shilpa Medicare Ltd has announced the U.S. Food and Food Administration (USFDA) has approved the Company's second NDA...
Shilpa Medicare successfully completes Phase 3 studies of SMLNUD07 - NorUDCA Ruchika Sharma26 Aug 2024 11:36 AM ISTShilpa Medicare Ltd plans to submit these Phase 3 clinical trial findings at the earliest to the CDSCO, India for seeking marketing authorization in...
Shilpa Medicare successfully completes Phase 1 clinical trial for Recombinant Human Albumin 20% Ruchika Sharma8 Aug 2024 4:21 PM ISTKarnataka: Shilpa Medicare Limited has announced the successful completion of its Phase 1 clinical trial for recombinant human albumin 20%...
